Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy.

Autor: Manzar GS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Alam MBE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Lynn EJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Karpinets TV; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Harris T; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Lo D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Yoshida-Court K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Napravnik TC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Sammouri J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Lin D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Andring LM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Bronk J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wu X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Sims TT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Mathew G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Schmeler KM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Eifel PJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Lin LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Joyner MM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: lcolbert@mdanderson.org.

Publikováno v: Brachytherapy [Brachytherapy] 2024 Mar-Apr; Vol. 23 (2), pp. 123-135. Date of Electronic Publication: 2023 Dec 20.

Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring.

Autor: Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: lcolbert@mdanderson.org., El Alam MB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wang R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Karpinets T; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lo D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lynn EJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Harris TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Elnaggar JH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; LSU School of Medicine, Louisiana State University, Baton Rouge, LA 70803, USA., Yoshida-Court K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tomasic K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bronk JK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sammouri J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yanamandra AV; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Olvera AV; Departments of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Carlin LG; Departments of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sims T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Delgado Medrano AY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Napravnik TC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., O'Hara M; Department of Thoracic Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lin D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Abana CO; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Li HX; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Eifel PJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Joyner M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lin L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ramondetta LM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Futreal AM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Schmeler KM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Mathew G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dorta-Estremera S; Department of Microbiology and Medical Zoology, University of Puerto Rico, San Juan, PR 00921, USA., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wu X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wong M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Taniguchi C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Petrosino JF; Department of Molecular Virology and Microbiology, The Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, TX 77030, USA., Sastry KJ; Department of Thoracic Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Okhuysen PC; Departments of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Martinez SA; Metabolomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tan L; Metabolomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Mahmud I; Metabolomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lorenzi PL; Metabolomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wargo JA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; LSU School of Medicine, Louisiana State University, Baton Rouge, LA 70803, USA; Platform for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publikováno v: Cancer cell [Cancer Cell] 2023 Nov 13; Vol. 41 (11), pp. 1945-1962.e11. Date of Electronic Publication: 2023 Oct 19.

Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment.

Autor: Wu J; University of Texas Medical Branch, Galveston, Texas; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Lakomy DS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas; Dartmouth Geisel School of Medicine, Hanover, New Hampshire., Fellman BM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas., Salcedo MP; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas; Obstetrics and Gynecology Department, Federal University of Health Sciences/Irmandade Santa Casa de Misericordia, Porto Alegre, Brazil., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas., Jhingran A; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Klopp AH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Iyer RB; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas., Jimenez C; Department of Endocrinology, University of Texas MD Anderson Cancer Center, Houston, Texas., Colbert LE; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Eifel PJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Schmeler KM; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas., Lin LL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: LLLin@mdanderson.org.

Publikováno v: Practical radiation oncology [Pract Radiat Oncol] 2022 Sep-Oct; Vol. 12 (5), pp. e423-e433. Date of Electronic Publication: 2022 Apr 05.

A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation.

Autor: Armbruster SD; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. sdarmbruster@carilionclinic.org.; Division of Gynecologic Oncology and Reproductive Medicine, Virginia Tech Carilion School of Medicine, 1 Riverside Circle Suite 300, Roanoke, VA, 24016, USA. sdarmbruster@carilionclinic.org., Fellman BM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Eifel PJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Ramondetta LM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Frumovitz M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Jan; Vol. 29 (1), pp. 213-222. Date of Electronic Publication: 2020 Apr 27.

Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis.

Autor: Corrigan KL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yoder A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., De B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Joyner MM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Eifel PJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lu KH; Department of Gynecology Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: AKlopp@mdanderson.org.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2022 Mar; Vol. 164 (3), pp. 550-557. Date of Electronic Publication: 2021 Dec 30.